Epitalon for Health & Longevity - Quick Reference Sheet

Epitalon for Health & Longevity

Created on 09/30/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Sonnet 5.5 – Audit

Epitalon is a synthetic chain of four amino acids, developed in Russia from an animal brain-gland extract and marketed to influence biological aging, mainly as an injectable research product. No benefit reaches high or medium confidence: human data are small and come mainly from its developers, while lifespan and tumor findings come from animals and cultured cells. Reported risks are mostly theoretical or concern product quality. (Full Review)

Protocol

Commonly circulated course
5–10 mg daily for 10–20 days
By subcutaneous or intramuscular injection, repeated one to three times yearly; extrapolated from extract trials
Time of day
Evening
Commonly described to match the night melatonin peak seen in monkeys; no trial compared timings
Single versus split dosing
One daily dose
Some vendors split it into morning and evening doses; no comparison exists
Time to effect
Melatonin Rhythm in Older Adults
7–10-day course
Monkey melatonin changes followed a 7–10-day course; no controlled human data exist
Sleep Quality and Insomnia
Anecdotal
Reported sleep changes are anecdotal; no controlled human data exist
Lifespan Extension in Animals
Months
Rodent lifespan effects took months; no controlled human data exist

Benefits

Contraindications
  • Active cancer or cancer treated within the past 5 years
  • Pregnancy or breastfeeding
  • Age under 18 years
  • Solid-organ transplant recipients or others on immunosuppressants
  • Prior allergic reaction to a peptide injection or to any component of the preparation
Key Interactions
  • Blood-sugar-lowering medications (metformin, insulin, glipizide), monitor
  • Cancer treatments (cisplatin, tamoxifen, radiotherapy), caution
  • Sedative-hypnotics (sleep medications: zolpidem, eszopiclone), monitor
  • Over-the-counter sleep aids (diphenhydramine, doxylamine), monitor
  • Melatonin supplements, monitor
  • Telomerase-targeting supplements (cycloastragenol, TA-65, astragalus extract), caution
  • Other injectable peptides (thymalin, BPC-157, TB-500, Semax), caution
  • Disrupted lighting and shift work, monitor

Risk & Side Effects

  • High:
  • Medium:
  • Low: Unverified Product Identity and Purity
  • Speculative: Immune and Injection-Site Reactions; Cancer Promotion via Telomere Maintenance; Lower Night Melatonin with Normal Pineal Function; Unstudied Long-Term and Reproductive Safety

Monitoring

Marker Target Why
Fasting glucose 75–90 mg/dL Glucose handling changed in aged monkeys
HbA1c 4.6–5.3% Three-month glucose average
Fasting insulin 2–6 µIU/mL Insulin response normalized in old monkeys
Complete blood count with differential White cells 4.5–7.0 ×10³/µL, no abnormal differential Immune effects seen in animals
hs-CRP Under 1.0 mg/L General inflammation marker
Night melatonin (saliva or urinary 6-sulfatoxymelatonin) No established target; track change from own baseline The main marker reported to shift
Blood telomere length (optional) No established target; track change from own baseline The intended target of telomerase claims

Cadence: Baseline before a first course; glucose regulation markers, blood counts, and inflammation markers at the end of each course (about 2–4 weeks after starting), again at 3 months, then every 6–12 months; night melatonin 2–4 weeks after a course; telomere length no more often than every 12 months in the same laboratory

Qualitative Assessment

  • Sleep quality, sleep onset, and morning refreshment
  • Daytime energy and mood
  • Cognitive clarity and stress resilience
  • Injection-site tolerance and any new symptoms